Rigosertib

CAS No. 592542-59-1

Rigosertib ( ON-01910 )

Catalog No. M24584 CAS No. 592542-59-1

Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 (IC50: 9 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 31 In Stock
5MG 50 In Stock
10MG 87 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Rigosertib
  • Note
    Research use only, not for human use.
  • Brief Description
    Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 (IC50: 9 nM).
  • Description
    Rigosertib is a selective and non-ATP-competitive inhibitor of PLK1 (IC50: 9 nM). Rigosertib is a multi-kinase inhibitor and a selective anti-cancer agent, which induces apoptosis by inhibition of the PI3 kinase/Akt pathway, promotes the phosphorylation of histone H2AX and induces G2/M arrest in the cell cycle.
  • Synonyms
    ON-01910
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis;BCR-ABL;Cdk1;Flt1;Fyn;PDGFR;PLK1;PLK2;Src
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    592542-59-1
  • Formula Weight
    451.5
  • Molecular Formula
    C21H25NO8S
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:75 mg/mL (166.12 mM; Need ultrasonic)
  • SMILES
    COC1=C(C=C(C=C1)CS(=O)(=O)/C=C/C2=C(C=C(C=C2OC)OC)OC)NCC(=O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Xu F, et al. Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signalingtransduction pathways in high-grade myelodysplastic syndrome. Sci Rep. 2014 Dec 4;4:7310.
molnova catalog
related products
  • CFI-400437 dihydroch...

    CFI-400437 is a selective and potent polo-like kinase 4 (PLK4) inhibitor.

  • Volasertib

    Volasertib (BI 6727) is a potent, selective Polo-like kinase (PLK) inhibitor with IC50 of 0.87, 5 and 56 nM for PLK1, 2 and 3, respectively.

  • GW843682X

    GW843682X is a selective, ATP-competitive inhibitor of PLK1 and PLK3, with IC50s of 2.2 nM and 9.1 nM, respectively, and is also >100-fold selective against ~30 other kinases.